Financial Daily from THE HINDU group of publications
Wednesday, Sep 07, 2005
Financial Daily from THE HINDU group of publications Wednesday, Sep 07, 2005 |
|
|
|
|
|
Opinion
-
Letters Public health
Policy-makers should identify major ailments for which a notified list of "public drugs" with a reasonable profit margin is prescribed. Regulation of profit and not price should be the criteria in pricing of drugs. Such a step will create an win-win situation, without resulting in a conflict of interest. Similarly, a compulsory and effective cost audit mechanism will check profit-centric manufacturers. The Medical Council of India, through its code of conduct, should encourage doctors to prescribe reasonably priced drugs. The government's initiative to aggressively promote traditional systems of Ayurveda, Siddha and Unani will act as a bulwark against the malpractices of doctors and drug manufacturers. Suhas S. Bohra Mumbai
Letters to the editor and contributions can be sent by e-mail to: bleditor@thehindu.co.in
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|